Page 10 - Nucleus Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The early study results come amid worry about whether a vaccines being rolled out worldwide will be strong enough against new variants.

Tapeworm, vertigo and pancreatitis drugs are being trialled as COVID-19 treatments By the Specialist Reporting Team's Alison Branley and national medical reporter Sophie Scott Posted SunSunday 24 updated MonMonday 25 Australian researchers are part of global efforts to trial potential COVID-19 treatments. ( Print text only Cancel With COVID-19 vaccines on their way, it's time to breathe a sigh of relief right? Well, maybe not. Key points: It includes drugs to treat tapeworm, pancreatitis, vertigo and cancer Experts warn clinical trials don't always translate into effective human treatments M...

Manufacturing and trial delays have meant Australia’s third vaccine has slipped off the radar – but early trial data raises hopes it could offer strong protection against and even halt the virus' spread.

COVID-19 swab in lab Photo: Getty Images A Burnaby biotech company is partnering with a global pharmaceutical giant on research into advancing delivery of oral vaccines, including for COVID-19. Symvivo Corporation, a clinical-stage biotechnology company that has a proprietary bacTRL gene delivery platform, announced Tuesday that it has entered into a research collaboration with Merck Sharp and Dohme Corp. Under the terms of the agreement, Merck receives an option to take an exclusive license to Symvivo’s bacTRL platform technology for use in advancing delivery of oral vaccines. “We are ex...